Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
about
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancerCloning and characterization of a new isoform of the interleukin 1 receptor antagonistMolecular cloning and characterization of a second subunit of the interleukin 1 receptor complexFlow cytometric analysis of cytokine receptors on human Langerhans' cells. Changes observed after short-term cultureSoluble type II interleukin 1 (IL-1) receptor binds and blocks processing of IL-1 beta precursor and loses affinity for IL-1 receptor antagonistInterleukin-1 in the pathogenesis and treatment of inflammatory diseasesOsteoimmunology: interactions of the bone and immune systemKeratinocyte expression of the type 2 interleukin 1 receptor mediates local and specific inhibition of interleukin 1-mediated inflammationExpression of a long pentraxin, PTX3, by monocytes exposed to the mycobacterial cell wall component lipoarabinomannanThe type II "receptor" as a decoy target for interleukin 1 in polymorphonuclear leukocytes: characterization of induction by dexamethasone and ligand binding properties of the released decoy receptorProtection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritisThe Role of IL-1 Family Members and Kupffer Cells in Liver RegenerationRegulatory Role of IL-1R8 in Immunity and DiseaseIL-1 receptor 2 (IL-1R2) and its role in immune regulationThe role of inflammasome in Alzheimer's diseaseStructural insights into the assembly and activation of IL-1β with its receptorsCorticosteroids in acute respiratory failureRegulation of serum amyloid A protein expression during the acute-phase responseRegulation of IGF-I function by proinflammatory cytokines: at the interface of immunology and endocrinologyBacillus anthracis' lethal toxin induces broad transcriptional responses in human peripheral monocytesCytokine-mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonistIntracellular interleukin-1 receptor 2 binding prevents cleavage and activity of interleukin-1α, controlling necrosis-induced sterile inflammationIdentification and characterization of two members of a novel class of the interleukin-1 receptor (IL-1R) family. Delineation of a new class of IL-1R-related proteins based on signalingNeutrophil cell surface receptors and their intracellular signal transduction pathways.Sleep-wake behavior and responses to sleep deprivation of mice lacking both interleukin-1 beta receptor 1 and tumor necrosis factor-alpha receptor 1.Alternate splicing of interleukin-1 receptor type II (IL1R2) in vitro correlates with clinical glucocorticoid responsiveness in patients with AIED.Transcriptomic analysis of the temporal host response to skin infestation with the ectoparasitic mite Psoroptes ovisUltrasensitive response motifs: basic amplifiers in molecular signalling networks.Cloning and characterization of the rainbow trout (Oncorhynchus mykiss) type II interleukin-1 receptor cDNA.Unique genetic responses revealed in RNA-seq of the spleen of chickens stimulated with lipopolysaccharide and short-term heat.Phase 1 trial of recombinant human interleukin-1 beta (rhIL-1 beta), carboplatin, and etoposide in patients with solid cancers: Southwest Oncology, Group Study 8940.Expression and function of TNF and IL-1 receptors on human regulatory T cells.IL-1beta processing in host defense: beyond the inflammasomes.Deficient spontaneous in vitro apoptosis and increased tmTNF reverse signaling-induced apoptosis of monocytes predict suboptimal therapeutic response of rheumatoid arthritis to TNF inhibitionHumoral sleep regulation; interleukin-1 and tumor necrosis factorSoluble cytokine receptors: basic immunology and clinical applications.Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy.Cytokine gene variations associated with trait and state anxiety in oncology patients and their family caregivers.Structural pathways of cytokines may illuminate their roles in regulation of cancer development and immunotherapy."Inflammatory" cytokines: neuromodulators in normal brain?
P2860
Q22008593-E7D6671D-A25B-4482-9A91-B9710E23BE6CQ24321369-5CBDD446-D58C-445F-BA79-9C1879BF12ACQ24321703-4AC655E9-1792-4CB8-AE7E-66B5BA1E69AFQ24541457-617E0F1D-E4FD-4536-BEA8-AD26A9D590FBQ24563274-ACCB72EC-7157-423E-A97D-8E00812541A5Q24606766-167C24B8-ABBF-40CA-B142-CD914932EEF5Q24655113-D975AAE7-2E16-471B-989B-C35992921A22Q24673428-9E858F67-CB90-42E4-A1E2-E26C5DCCC413Q24675983-1158EEC3-9B6E-408A-AD9C-D7CD37D8CFC8Q24680185-29D5C5C9-C014-44AC-9C33-8B68DCF3E09FQ24792053-5AB2914D-8B14-493B-9E25-38E4068CE5F7Q26752405-BCB248D6-E04F-4B5C-A1D1-7AF09A3C69FEQ26752524-E8A2B981-5D97-4387-9AC6-31485F8A8310Q26826872-9FA63536-2431-4E95-A5DC-661ECDEA6112Q26996822-ED93D3DE-B8F7-4B52-AE5F-B64660577D0EQ27664215-62D291E1-EEAF-46CA-8BDB-FC96DBB71D44Q28145486-F10C0426-3A95-4B8B-BE16-A65A30ACBD5BQ28281545-42A4765D-5BCE-4D80-867E-0B8187F6B3CAQ28386983-4986038B-44A5-4B22-8349-5A8FD770FC90Q28389931-28386C85-C7DE-4351-8202-502C3DC26250Q28583823-31F1C73D-046A-4039-8A51-C46D9E0EB7B4Q28591187-431A1DC7-F737-4A18-AA93-94680FFFDBA2Q28592094-45176271-7F40-4D0E-B325-93D846051107Q30009577-89A2F8DA-09A4-4692-8011-2D5E4F0B598BQ30430842-EDBB6AAB-3459-491A-BE3C-ECE7FC20019AQ30490048-60619F5E-A374-4783-95E2-6BC862B55C80Q30500185-89E45561-B7A9-4802-9BF5-E1B977BB0009Q30541676-F8964C67-DC58-4BC8-A4EB-AF75ED4E95BBQ30975538-7279A048-22EC-442E-A516-0FD2C47ED469Q31159823-CCDE3614-B517-42DF-BF5B-AA5DC921E274Q33500440-E166A5BB-5469-4BFC-B7E8-5AE3BD3E8E60Q33523291-3645B309-F201-4289-86E8-EC31AD37442CQ33535878-A1B3647A-3EEC-4A4C-B3AC-F64102FB6F55Q33643146-D4141D28-2B12-4A19-9FCB-001899ABA753Q33648273-26C8B8AE-EF7A-430B-8E7C-99C7BD5F51CBQ33688222-B968359F-24B3-4076-9A5B-FFC1CBB03D1EQ33742612-7683DEFE-8235-442D-A5D8-6AB484C09BDBQ33809141-BB797216-3B2D-42CF-A606-685757F75CF2Q33820227-4835775D-AB69-4D9B-887E-8EEC46C9C9E5Q33824014-8367DD25-D07C-43FC-834A-C09D0A3A701B
P2860
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
description
1993 nî lūn-bûn
@nan
1993 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@ast
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@en
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@en-gb
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@nl
type
label
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@ast
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@en
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@en-gb
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@nl
prefLabel
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@ast
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@en
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@en-gb
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@nl
P2093
P50
P921
P3181
P356
P1433
P1476
Interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4
@en
P2093
A Mantovani
N Polentarutti
P304
P3181
P356
10.1126/SCIENCE.8332913
P407
P577
1993-07-01T00:00:00Z